From: Guava pomace: a new source of anti-inflammatory and analgesic bioactives
Groups | Dose (mg/kg) | Mean Edema ∆V mL (percent inhibition) | ||||
---|---|---|---|---|---|---|
1 h | 2 h | 3 h | 4 h | 5 h | ||
Control | - | 0.10 ± 0.01 | 0.12 ± 0.01 | 0.14 ± 0.01 | 0.15 ± 0.01 | 0.09 ± 0.01 |
Indo | 10 | 0.03 ± 0.01* | 0.03 ± 0.01** | 0.04 ± 0.01** | 0.07 ± 0.01* | 0.08 ± 0.01 |
(62) | (68) | (70) | (48) | (10) | ||
GPE | 300 | 0.05 ± 0.01* | 0.05 ± 0.01* | 0.08 ± 0.00* | 0.09 ± 0.01 | 0.05 ± 0.01 |
(46) | (56) | (38) | (35) | (42) | ||
GPE | 100 | 0.05 ± 0.01* | 0.08 ± 0.01* | 0.10 ± 0.01 | 0.11 ± 0.01 | 0.10 ± 0.01 |
(51) | (42) | (27) | (4) | (13) | ||
GPE | 30 | 0.06 ± 0.01 | 0.07 ± 0.01 | 0.11 ± 0.01 | 0.09 ± 0.01 | 0.11 ± 0.03 |
(41) | (40) | (20) | (39) | (-) |